Following FDA rejections, Regeneron and Scholar Rock are turning to other facilities to clear regulatory logjams created by ...

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA levels in a dose-related manner. MIAMI, FLORIDA / ACCESS Newswire / November ...

The Wistar Institute received a $600,000 grant from the William Penn Foundation to continue its Biomedical Technician ...

In the biotech field, alongside the widely recognized industry giants, some relatively smaller companies focused on specific niches are also demonstrating considerable potential through solid R& ...

Shares of biotech giant Regeneron Pharmaceuticals (NASDAQ: REGN) have staged a notable rebound, with a single-day surge exceeding 5%, drawing market attention. This rally interrupts a nearly ...

Prognostications that the AI bubble is grossly overbought have been increasing. The fact that the Magnificent 7 AI stocks, ...

Axsome Therapeutics boasts a deep late-stage pipeline with billions in potential revenue opportunity. Exelixis' core ...

As unpopular as she has been in parts of the real estate community, Mayor Michelle Wu has endeared herself with another ...

Angelini’s investments will be made through its Angelini Ventures arm. EIB and Angelini plan to support between seven and 10 ...

It took three years after buying the office building to convert it and ink a lease with Curve Biosciences.

Scientists have found that common foods can contain hidden contaminants formed during cooking or through environmental ...

Regeneron is adding its name to Tessera Therapeutics’ unique in vivo gene writing program, inking a deal that lets it in on a ...